Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma.

Harousseau JL, Dimopoulos MA, Wang M, Corso A, Chen C, Attal M, Spencer A, Yu Z, Olesnyckyj M, Zeldis JB, Knight RD, Weber DM.

Haematologica. 2010 Oct;95(10):1738-44. doi: 10.3324/haematol.2009.015917. Epub 2010 May 11.

2.

Management of the relapsed/refractory myeloma patient: strategies incorporating lenalidomide.

Richardson P.

Semin Hematol. 2005 Oct;42(4 Suppl 4):S9-15. Review.

PMID:
16344100
3.

Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.

Badros A, Goloubeva O, Dalal JS, Can I, Thompson J, Rapoport AP, Heyman M, Akpek G, Fenton RG.

Cancer. 2007 Sep 1;110(5):1042-9. Review.

4.

Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide.

Mariz JM, Esteves GV.

Curr Opin Oncol. 2012 Jan;24 Suppl 2:S3-11. doi: 10.1097/01.cco.0000410243.84074.dc. Review.

PMID:
22245806
5.

Lenalidomide in the treatment of multiple myeloma: a review.

Armoiry X, Aulagner G, Facon T.

J Clin Pharm Ther. 2008 Jun;33(3):219-26. doi: 10.1111/j.1365-2710.2008.00920.x. Review.

PMID:
18452408
6.

Lenalidomide in myelodysplastic syndrome and multiple myeloma.

Shah SR, Tran TM.

Drugs. 2007;67(13):1869-81. Review.

PMID:
17722955
7.

Spotlight on lenalidomide in relapsed or refractory multiple myeloma.

Scott LJ, Lyseng-Williamson KA.

BioDrugs. 2011 Oct 1;25(5):333-7. doi: 10.2165/11207120-000000000-00000. Review.

PMID:
21942918
8.

Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma.

Scott LJ, Lyseng-Williamson KA.

Drugs. 2011 Mar 26;71(5):625-49. doi: 10.2165/11206420-000000000-00000. Review.

PMID:
21443285
9.

[Successful treatment with lenalidomide plus dexamethasone for multiple myeloma complicated with systemic amyloidosis].

Fuchida S, Okano A, Hatsuse M, Murakami S, Haruyama H, Shimazaki C.

Rinsho Ketsueki. 2012 Nov;53(11):1937-9. Review. Japanese.

PMID:
23257677
10.

Lenalidomide treatment for multiple myeloma: systematic review and meta-analysis of randomized controlled trials.

Yang B, Yu RL, Chi XH, Lu XC.

PLoS One. 2013 May 14;8(5):e64354. doi: 10.1371/journal.pone.0064354. Print 2013. Review.

11.

Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients.

Wang J, Guo H, Zhou X.

Onco Targets Ther. 2015 Jun 2;8:1277-84. doi: 10.2147/OTT.S65762. eCollection 2015. Review.

Supplemental Content

Support Center